share_log

Cantor Fitzgerald Reiterates Overweight on Mesoblast, Maintains $17 Price Target

Benzinga ·  Sep 21, 2023 08:58

Cantor Fitzgerald analyst Louise Chen reiterates Mesoblast (NASDAQ:MESO) with a Overweight and maintains $17 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment